Is etonogestrel typically purchased as API or through finished implants?

It is most commonly accessed via finished contraceptive implant products for clinical use; API is purchased when local formulation and regulatory pathways require it.

What differentiates a compliant etonogestrel API supplier?

A compliant supplier provides GMP manufacturing site coverage, per-lot CoA, controlled impurity specifications, and validated analytical documentation, with regulatory dossier linkage where your framework requires it.

Do API distributors qualify as suppliers for procurement?

Distributors can be workable procurement channels when they act as authorized resellers and provide full GMP, CoA, chain-of-custody, and documentation needed for release in your market.

What documents are essential for finished etonogestrel implant procurement?

In practice, you need in-country authorization, batch release records, stability and shelf-life documentation, and quality evidence for sterile device components.

What supply risk matters most for etonogestrel?

Allocation and lead-time volatility tied to API sourcing concentration and device manufacturing throughput are the key risks in many contraceptive implant markets.

etonogestrel: Pharmaceutical manufacturers, suppliers, and distributors

Subscribe to access the full database, or Start Trial
Applicant	Tradename	Generic Name	Dosage	NDA	NDA/ANDA	Supplier	Package Code	Package	Marketing Start
Organon	IMPLANON	etonogestrel	IMPLANT;IMPLANTATION	021529	NDA	Organon LLC	78206-145-01	1 BLISTER PACK in 1 CARTON (78206-145-01) / 1 IMPLANT in 1 BLISTER PACK	2021-06-01
Organon	NEXPLANON	etonogestrel	IMPLANT;IMPLANTATION	021529	NDA	Organon LLC	78206-145-01	1 BLISTER PACK in 1 CARTON (78206-145-01) / 1 IMPLANT in 1 BLISTER PACK	2021-06-01
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>NDA/ANDA	>Supplier	>Package Code	>Package	>Marketing Start

Last updated: April 24, 2026

What supplier categories can reliably provide etonogestrel?

Etonogestrel is a specialty steroid active ingredient (AI) used in contraceptive products and is supplied through three main channels:

API manufacturers (primary synthesis and bulk active supply)
Specialty chemical suppliers (commercial bulk API or API intermediates, depending on license and geography)
Finished-dosage manufacturers (implant/device and other delivery forms that either source API externally or integrate vertically)

Who supplies etonogestrel API and finished products in the market?

Etonogestrel is widely traded as an API for contraceptive implants (notably the etonogestrel implant brand market). Supplier lists vary by region because of licensing, tendering practices, and country-specific regulatory authorizations.

Typical supplier footprint seen in contraceptive implant supply chains

The market commonly includes:

Global contraceptive implant manufacturers that hold product dossiers and market authorizations
API producers that supply bulk etonogestrel to licensed pharmaceutical manufacturers under GMP controls
Distributor networks that contract with API producers for regional fulfillment and documentation packages

Practical mapping for procurement decisions

For procurement and vendor qualification, your actionable split is:

If you buy API: qualify an API manufacturer or an authorized distributor with complete GMP documentation and DMF access where applicable.
If you buy finished implants: qualify the marketing authorization holder or the contract manufacturer that produces the device under GMP.

Which finished-dose manufacturers supply etonogestrel implants?

Etonogestrel is most commonly supplied to patients through contraceptive implant systems. The manufacturer landscape depends on country approvals and tender cycles.

Actionable procurement targets for finished products:

Marketing authorization holders in each target geography (country-specific)
Contract manufacturing organizations (CMOs) producing the implant under the authorization holder’s quality system

What documentation suppliers must provide for etonogestrel?

For regulated procurement of either API or finished implants, suppliers typically must support:

API supplier documentation pack (typical)

GMP certificate(s) for the manufacturing site(s)
CoA (Certificate of Analysis) per lot
Specification sheet for etonogestrel (assay, impurities, residual solvents if relevant)
Analytical method descriptions or validated method summaries
Stability data and recommended storage conditions
Regulatory dossier linkage if you operate under a DMF/CEP model (where used in your region)

Finished product pack (typical)

Product dossier/regulatory authorization in-country
GMP and batch release documentation
Device component quality (container closure, implant sterile status, packaging validation)
Shelf-life and storage per label claims

What are the common commercial grades and forms?

Etonogestrel is supplied as:

API (bulk powder) for formulation
Finished implants where etonogestrel is loaded into a device and delivered via an applicator

The exact concentration of etonogestrel in implants and the delivery performance depend on the product design approved in each geography.

How should procurement teams evaluate supplier fit?

A procurement-grade evaluation for etonogestrel should be built around:

Regulatory fit: authorization holder status for finished products; DMF/CEP availability for API where required
Quality fit: impurity profile control capability and GMP compliance record
Supply fit: lead time stability, allocation risk, and batch release turnaround
Commercial fit: Incoterms, pricing structure, minimum order quantities, and change control responsiveness

Key Takeaways

Etonogestrel supply splits into API manufacturers and finished implant supply chains; supplier qualification differs by route.
For API, procurement hinges on GMP compliance, lot CoA integrity, impurity control, and regulatory dossier linkage.
For finished implants, procurement hinges on in-country regulatory authorization and batch release under the authorization holder’s quality system.
Vendor evaluation must be structured around regulatory fit, quality fit, supply fit, and commercial fit.

FAQs

Is etonogestrel typically purchased as API or through finished implants?
It is most commonly accessed via finished contraceptive implant products for clinical use; API is purchased when local formulation and regulatory pathways require it.
What differentiates a compliant etonogestrel API supplier?
A compliant supplier provides GMP manufacturing site coverage, per-lot CoA, controlled impurity specifications, and validated analytical documentation, with regulatory dossier linkage where your framework requires it.
Do API distributors qualify as suppliers for procurement?
Distributors can be workable procurement channels when they act as authorized resellers and provide full GMP, CoA, chain-of-custody, and documentation needed for release in your market.
What documents are essential for finished etonogestrel implant procurement?
In practice, you need in-country authorization, batch release records, stability and shelf-life documentation, and quality evidence for sterile device components.
What supply risk matters most for etonogestrel?
Allocation and lead-time volatility tied to API sourcing concentration and device manufacturing throughput are the key risks in many contraceptive implant markets.

References

[1] World Health Organization (WHO). (n.d.). WHO prequalification and product documentation resources (contraceptives and related APIs where applicable).
[2] U.S. FDA. (n.d.). Drug approvals and related information for contraceptive products (etonogestrel-containing products).
[3] European Medicines Agency (EMA). (n.d.). EMA assessment and product information for etonogestrel-containing contraceptive products.

Suppliers and packagers for generic pharmaceutical drug: etonogestrel

etonogestrel

Suppliers for the Pharmaceutical Drug ETONOGESTREL